Volume 2, Issue 10
The Effects of Quercetin on Proinflammatory Cytokine’s Levels in Postmenopausal Women with Metabolic Syndrome
Author: Lyubomyr V. Glushko, Anas H. Nasrallah, Sergiy V. Fedorov
Abstract: Abstract. Metabolic syndrome (MetS) is becoming a worldwide epidemic as a result of the increased prevalence of obesity and a sedentary lifestyle, and the prevalence of MetS in the adult population is relatively high. Many studies showed the high prevalence of metabolic syndrome among postmenopausal women. The purpose of our study was to investigate of quercetine’ influence on proinflammatory cytokines level in blood of postmenopausal women with MetS. The 39 postmenopausal women with MetS were referred to the study, and divided into 2 groups: 1st – control group (patients with MetS which treated by basic medication: RAAS blockers, acetylsalicylic acid and statin); 2nd – additionally used quercetine in dose 40 mg twice a day 30 min before meals. Quercetine is strong antiinflammation medicine which decreases IL-1, IL-6, Ltr B4 levels in blood serum.
Download Full Article: Click Here
Support Us
If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.
